Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Clinical trial NCT02100514 · COMPLETED
Trial details
- NCT number
- NCT02100514
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-28
- Primary completion
- 2016-07-15
- Enrollment
- 746
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.